Stockreport

Eupraxia Pharmaceuticals Reports Second Quarter 2024 Financial Results [Yahoo! Finance]

Eupraxia Pharmaceuticals Inc.  (EPRX) 
PDF company leveraging its proprietary DiffuSphere™ technology to optimize drug delivery for applications with significant unmet need, today announced its financial results [Read more]